Literature DB >> 8301102

Cyclosporin-induced hypertension precedes renal dysfunction and sodium retention in man.

N D Sturrock1, C C Lang, A D Struthers.   

Abstract

OBJECTIVE: To study the acute effects of cyclosporin on blood pressure, renal function and hormones within the first few hours of drug ingestion in healthy man.
DESIGN: A therapeutic (12 mg/kg) and a supratherapeutic (30 mg/kg) dose of cyclosporin were administered orally to 10 salt-replete normal healthy volunteers. Their renal haemodynamic parameters were assessed by inulin and para-aminohippurate clearances, and their blood pressure was recorded every 20 min.
RESULTS: Cyclosporin had an acute hypertensive effect while having no effect on sodium excretion or renal function. The earliest renal effect of cyclosporin was on water handling, with a marked antidiuretic effect.
CONCLUSIONS: Our findings contradict previous data and currently held views regarding the pathogenesis of cyclosporin-induced hypertension. In particular, we have demonstrated that hypertension precedes any measurable change in renal haemodynamic parameters and occurs without apparent overall alterations in renal sodium excretion. We have also found that an antidiuresis is a very early renal effect of cyclosporin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8301102

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

Review 1.  Cyclosporin-induced hypertension: incidence, pathogenesis and management.

Authors:  S J Taler; S C Textor; V J Canzanello; L Schwartz
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

2.  Use of human organ slices to evaluate the biotransformation and drug-induced side-effects of pharmaceuticals.

Authors:  A E Vickers
Journal:  Cell Biol Toxicol       Date:  1994-12       Impact factor: 6.691

Review 3.  Pathogenesis of calcineurin inhibitor-induced hypertension.

Authors:  Ewout J Hoorn; Stephen B Walsh; James A McCormick; Robert Zietse; Robert J Unwin; David H Ellison
Journal:  J Nephrol       Date:  2012 May-Jun       Impact factor: 3.902

Review 4.  [Recommendations when switching therapy from immunosuppressive drugs to dupilumab in patients with atopic dermatitis].

Authors:  Johannes Wohlrab; Ulrich Mrowietz; Stephan Weidinger; Thomas Werfel; Andreas Wollenberg
Journal:  Hautarzt       Date:  2021-04       Impact factor: 0.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.